Stockscreener 앱 받기
1.55
7.64%
0.11
시간 외 거래:
1.58
0.03
+1.94%
전일 마감가:
$1.44
열려 있는:
$1.58
하루 거래량:
15,122
Relative Volume:
0.80
시가총액:
$63.74M
수익:
$1.88M
순이익/손실:
$-16.06M
주가수익비율:
-7.8362
EPS:
-0.1978
순현금흐름:
$-50.09M
1주 성능:
+5.44%
1개월 성능:
-9.36%
6개월 성능:
-19.27%
1년 성능:
-27.23%
1일 변동 폭
$1.49
$1.615
1주일 범위
$1.37
$1.66
52주 변동 폭
$1.21
$3.44
Beyondspring Inc Stock (BYSI) Company Profile
명칭
Beyondspring Inc
전화
646-528-4184
주소
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Compare BYSI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
1.55 | 59.21M | 1.88M | -16.06M | -50.09M | -0.1978 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-12-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-12-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-12-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-09-09 | 개시 | Robert W. Baird | Outperform |
| 2021-08-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-04-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-01-11 | 개시 | BofA Securities | Buy |
| 2020-12-29 | 개시 | Evercore ISI | Outperform |
| 2020-02-07 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Nomura | Buy |
| 2019-12-03 | 개시 | William Blair | Outperform |
| 2019-07-10 | 재확인 | H.C. Wainwright | Buy |
| 2019-04-30 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-10-25 | 재확인 | Maxim Group | Buy |
모두보기
Beyondspring Inc 주식(BYSI)의 최신 뉴스
BeyondSpring (BYSI) to Release Quarterly Earnings on Tuesday - MarketBeat
BeyondSpring (NASDAQ:BYSI) Stock Price Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth? - Sahm
BeyondSpring (NASDAQ:BYSI) Stock Price Up 0.1%Here's Why - MarketBeat
BYSI (BeyondSpring Inc. Ordinary Shares) posts narrower than expected Q4 2021 loss, shares rise nearly 3 percent on positive market reception.Beat Estimates - Cổng thông tin điện tử Tỉnh Sơn La
BeyondSpring : Corporate Presentation - marketscreener.com
BeyondSpring reports preclinical data on plinabulin-ADC combos - Investing.com
BeyondSpring reports preclinical data on plinabulin-ADC combos By Investing.com - Investing.com South Africa
BeyondSpring presents preclinical data on Plinabulin ADC combinations - StreetInsider
Cancer-drug combo cut animal deaths and extended survival in AACR study - Stock Titan
Recap Report: Whats the RSI of BeyondSpring Inc stock2026 Fed Impact & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Is BeyondSpring Inc exposed to political risk2026 Drop Watch & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Quarterly Earnings: Can BeyondSpring Inc maintain sales growth2026 Final Week & Precise Buy Zone Identification - baoquankhu1.vn
BeyondSpring Reports 2025 Year-End Financial Results - ADVFN
Are investors bullish on BeyondSpring (BYSI) Stock | Price at $1.82, Up 2.77%Crowd Risk Alerts - Newser
What is the long-term potential of BeyondSpring (BYSI) Stock | Price at $1.82, Up 3.58%Profit Surge - Newser
BeyondSpring (BYSI) director awarded 23,902 stock options at $1.64 strike price - Stock Titan
Pullback Watch: Can BeyondSpring Inc beat the S P 500Weekly Stock Report & AI Forecasted Stock Moves - baoquankhu1.vn
Here's Why We're A Bit Worried About BeyondSpring's (NASDAQ:BYSI) Cash Burn Situation - Yahoo Finance
Is BeyondSpring (BYSI) Stock Undervalued Now | Price at $1.75, Up 2.34%Investment Signal Network - Newser
BeyondSpring (NASDAQ:BYSI) Stock Passes Above 50 Day Moving Average – Here’s Why - Defense World
BYSI PE Ratio & Valuation, Is BYSI Overvalued - Intellectia AI
BeyondSpring Stock Crosses 50-Day Moving Average - National Today
BeyondSpring (NASDAQ:BYSI) Stock Crosses Above 50 Day Moving AverageShould You Sell? - MarketBeat
BeyondSpring (BYSI) director receives 22,165 stock options grant - Stock Titan
Director Delaney granted BYSI stock options under 2017 plan - Stock Titan
BeyondSpring (BYSI) director receives 21,730 options at $1.64 strike - Stock Titan
BeyondSpring (BYSI) awards CSO 17,840 stock options at $1.64 strike - Stock Titan
BeyondSpring (BYSI) CEO Huang Lan receives grant of 11,514 stock options - Stock Titan
BeyondSpring (BYSI) director Xu Sihai awarded 18,689 stock options at $1.64 - Stock Titan
BYSI Uptrend Accelerates on CEO - Newser
BeyondSpring Inc. (BYSI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 - Bitget
BeyondSpring (NASDAQ:BYSI) Trading Down 0.6%Should You Sell? - MarketBeat
Layoff Watch: Can BeyondSpring Inc beat the S P 5002026 Price Swings & AI Powered Market Entry Strategies - baoquankhu1.vn
Overcoming PD-1/L1 Resistance: Translational Insights with Plinabulin - marketscreener.com
BeyondSpring Inc. 2025 Annual Report – Plinabulin Clinical Progress, SEED TPD Platform, and Strategic Collaborations with Eli Lilly & Eisai - Minichart
EV Market: How does BeyondSpring Inc perform in inflationary periodsWeekly Trade Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
BeyondSpring Inc. (BYSI) Reports FY2025 Earnings - AlphaStreet
BeyondSpring Files 2025 Annual Report on Form 10-K - Bitget
BeyondSpring 10-K: $0M Revenue, $(0.02) EPS, net loss $(14.22)M - TradingView
BeyondSpring (NASDAQ: BYSI) posts 2025 loss and warns it needs more funding - Stock Titan
BYSI: Net loss narrowed to $14.2M in 2025 as Plinabulin advanced in global NSCLC trials - TradingView — Track All Markets
BeyondSpring Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
BeyondSpring Inc. Confirms Phase 3 Overall Survival Benefit for Plinabulin in NSCLC and Plans DUBLIN-4 Study - quiverquant.com
Jobs Data: How does BeyondSpring Inc compare to its peersTrade Analysis Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
BeyondSpring (NASDAQ: BYSI) narrows 2025 loss as Plinabulin Phase 3 data drive new trial - Stock Titan
Wall Street Recap: Whats the RSI of BeyondSpring Inc stockPortfolio Return Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
BeyondSpring (BYSI) Stock Analysis Report | Financials & Insights - Benzinga España
Buyback Watch: Will BeyondSpring Inc stock go up in YEAR2026 Breakouts & Fast Momentum Entry Tips - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Beyondspring Inc (BYSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.77%
0.25%
자본화:
|
볼륨(24시간):